Parvati Ramchandani
Table of contents :
Cover
……Page 1
Preface……Page 2
Clinical Approach to the Prostate: An Update……Page 3
Epidemiology……Page 4
Medical therapy……Page 5
Combination therapy……Page 6
Laser therapy……Page 7
Risk factors……Page 8
Evaluation and screening……Page 9
Radical surgery……Page 10
External beam radiation……Page 11
National Institutes of Health category II prostatitis……Page 12
References……Page 13
Prostatitis……Page 18
Chronic bacterial prostatitis……Page 19
Prostate abscess……Page 20
Chronic nonbacterial prostatitis/chronic pelvic pain syndrome……Page 22
Granulomatous prostatitis……Page 24
Evaluation of the ejaculatory ducts……Page 25
Partial ejaculatory duct stenoses……Page 26
References……Page 28
Anatomy and embryology……Page 31
Benign prostatic hyperplasia……Page 32
Prostate-specific antigen……Page 33
Patient preparation……Page 34
Anesthesia……Page 35
Contraindications/complications……Page 36
References……Page 37
Initial clinical assessment of benign prostatic hyperplasia……Page 40
Urologic management……Page 42
Anatomy of the prostate……Page 43
Pathogenesis and clinical effects of benign prostatic hyperplasia……Page 44
Appearance of benign prostatic hyperplasia on transrectal ultrasound……Page 46
Methods of estimating prostate size……Page 47
Prostatic contour……Page 50
Ultrasound classification of benign prostatic hyperplasia……Page 52
Postoperative changes……Page 58
References……Page 59
Prostate cancer imaging……Page 62
Ultrasound techniques……Page 63
Disease state 2: patients who have clinically localized prostate cancer……Page 64
MR imaging to differentiate T2 from T3 disease……Page 65
The use of lymphtrophic nanoparticle MR imaging to identify lymph node involvement……Page 66
Disease state 3: rising prostate-specific antigen……Page 67
Novel radiolabeled antibody techniques……Page 68
Summary……Page 69
References……Page 70
Role of MR imaging in prostate cancer diagnosis……Page 74
MR imaging for depiction of known prostatenbspcancer……Page 75
MR imaging for local staging of prostate cancer……Page 76
MR spectroscopy and MR spectroscopic imaging……Page 77
Added value for MR spectroscopic imaging for local tumor staging……Page 78
Current trends in management of localized prostate cancer……Page 79
Dynamic contrast-enhanced MR imaging……Page 80
Multimodality MR imaging of prostate cancer……Page 81
Post therapy/recurrence……Page 82
References……Page 83
Image-Guided Brachytherapy for Prostate Cancer……Page 86
Low dose rate brachytherapy: ultrasound guidance……Page 88
MR-guided permanent prostate brachytherapy: experience from the Brigham and Women’s Hospital……Page 93
Summary……Page 97
References……Page 98
Embryology and development……Page 100
Utricle and mUllerian duct cysts……Page 101
Prune-belly syndrome……Page 102
Anorectal malformations……Page 103
Inflammatory diseases……Page 104
Summary……Page 106
References……Page 107
Reviews
There are no reviews yet.